This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Fundaciüblica Andaluza Progreso Y Salud, Rexgenero Biosciences S.l., Servicio Andaluz De Salud. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Inmaculada Concepción Herrera Arroyo: Innovator in Cell Therapy
Introduction
Inmaculada Concepción Herrera Arroyo is a notable inventor based in Cordova, Spain. He has made significant contributions to the field of medical technology, particularly in the treatment of lower extremity peripheral artery disease. His innovative approach has led to the development of a unique cell suspension that utilizes autologous or allogeneic adult bone marrow-derived white blood cells.
Latest Patents
Herrera Arroyo holds a patent for a cell suspension designed for therapeutic use in patients suffering from lower extremity peripheral artery disease. This invention involves a cell suspension enriched for mononuclear cells, ensuring that more than 25% of the white blood cells present are mononuclear. This advancement has the potential to improve treatment outcomes for patients with this condition.
Career Highlights
Throughout his career, Inmaculada Concepción Herrera Arroyo has worked with prominent organizations such as Fundación Pública Andaluza Progreso y Salud and Rexgenero Biosciences S.L. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Jonathan Robert Barclay Dupere and Liesbeth De Jong. Their collaborative efforts have further enhanced the impact of his inventions and research in the medical field.
Conclusion
Inmaculada Concepción Herrera Arroyo is a distinguished inventor whose work in cell therapy has the potential to transform the treatment of peripheral artery disease. His innovative contributions and collaborations highlight the importance of research and development in advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile